RNAs are an incredibly valuable but severely underexploited class of drug ... in RNA-targeted small-molecule drug design and development. Azor has developed AI and physics-based computational ...

“Among other benefits, RNA-based drugs overcome a key problem: patient adherence to medications for chronic conditions,” says Ray. “Instead of relying on the patient to take more than 300 ...

In the microscopic world of bacteria, gene transfer is a powerful mechanism that can alter cellular function, drive ...

Vice President RNA Formulation & Drug Delivery, BioNTech RNA Pharmaceuticals Development of Formulations for Delivery of RNA and Small Molecules Shalini Andersson, Senior Director and Head of New ...

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid nanoparticles encapsulating messenger RNA (mRNA) to the immune system of ...

RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA vaccines and double-stranded RNA (dsRNA) therapies. But while health care ...

RNA-based drug discovery for spinal muscular atrophy: a story of small molecules and antisense oligonucleotides.

Biogen has made a further push into RNA-based drug discovery via a collaboration with Envisagenics, which applies artificial intelligence RNA sequencing data to discover new drug targets and ...

The failures of ophthalmology drug development ... company's RNA-based therapy for Dravet syndrome is not just another seizure treatment but a potential breakthrough in disease modification ...

“But this is just a proof-of-concept study. By tweaking the nanoparticle composition, we could deliver other RNA-based drugs to different organs. There’s a saying: “’’It’s all in the ...